• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 3. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Recent Advances in the Research of 2-Amino-5-fluorobenzothiazole (CAS: 20358-07-0)

2-Amino-5-fluorobenzothiazole (CAS: 20358-07-0) is a fluorinated benzothiazole derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile pharmacological properties. Recent studies have explored its potential as a key scaffold in the development of novel therapeutic agents, particularly in oncology and neurodegenerative diseases. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications.

One of the most notable advancements in the research of 2-Amino-5-fluorobenzothiazole is its role as a precursor in the synthesis of kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent inhibitory activity against cyclin-dependent kinases (CDKs), which are critical targets in cancer therapy. The study highlighted the compound's ability to selectively inhibit CDK4/6, leading to cell cycle arrest in breast cancer cell lines. These findings suggest that 2-Amino-5-fluorobenzothiazole-based inhibitors could serve as promising candidates for targeted cancer therapies.

In addition to its anticancer properties, recent research has also investigated the neuroprotective effects of 2-Amino-5-fluorobenzothiazole. A study published in ACS Chemical Neuroscience in 2024 reported that this compound can modulate the aggregation of amyloid-beta (Aβ) peptides, which are implicated in the pathogenesis of Alzheimer's disease. The researchers found that 2-Amino-5-fluorobenzothiazole derivatives effectively reduced Aβ aggregation and mitigated neurotoxicity in vitro, offering a potential avenue for the development of Alzheimer's therapeutics.

The synthesis and optimization of 2-Amino-5-fluorobenzothiazole derivatives have also been a focus of recent research. A 2023 paper in Organic & Biomolecular Chemistry detailed a novel, high-yield synthetic route for this compound using palladium-catalyzed cross-coupling reactions. This method not only improved the efficiency of synthesis but also enabled the introduction of diverse functional groups, thereby expanding the chemical space for drug discovery. Such advancements are critical for accelerating the development of new pharmacophores based on this scaffold.

Despite these promising developments, challenges remain in the clinical translation of 2-Amino-5-fluorobenzothiazole-based compounds. Issues such as pharmacokinetic properties, bioavailability, and off-target effects need to be addressed in future studies. However, the growing body of research underscores the potential of this compound as a versatile tool in medicinal chemistry. Continued exploration of its pharmacological properties and optimization of its derivatives will likely yield significant breakthroughs in the coming years.

In conclusion, 2-Amino-5-fluorobenzothiazole (CAS: 20358-07-0) represents a valuable scaffold in drug discovery, with demonstrated applications in oncology and neurodegenerative diseases. Recent studies have highlighted its potential as a kinase inhibitor and neuroprotective agent, while advances in synthetic chemistry have facilitated the development of novel derivatives. As research progresses, this compound is poised to play an increasingly important role in the development of next-generation therapeutics.

• 119256-40-5(4,6-difluoro-1,3-benzothiazol-2-amine)
• 352214-93-8(5,6-Difluorobenzodthiazol-2-amine)
• 20358-08-1(7-Fluorobenzo[d]thiazol-2-amine)
• 221654-65-5(2-Benzothiazolamine,6-fluoro-N-methyl-)
• 16162-28-0(DABBT)
• 20358-06-9(4-Fluorobenzo[d]thiazol-2-amine)
• 136-95-8(Benzo[d]thiazol-2-amine)
• 348-40-3(6-fluorobenzo[d]thiazol-2-amine)
• 78364-55-3(6-Fluoro-2-hydrazinyl-1,3-benzothiazole)
• 193828-79-4(Benzothiazole,5-fluoro-2-hydrazinyl-)